PatternsRadar
Sign in

MEDANTAGlobal Health Limited

NSE
Full chart
1,300.80INR-31.80 (-2.39%)Close · 6 Oct 2026
30 Jul 2026Last results
HealthcareSector
Healthcare ServicesIndustry
₹34,975 CrMarket cap
63.3P/E (TTM)
61.1%Delivery

Filings & corporate actions

15 results filed
CSV
Next results · Q2 FY27
Expected 7 Nov 2026 – 14 Nov 2026
Estimate: filed 38–45 days after quarter end, last 3 times
Dividend
₹0.50 per share · last 14 Aug 2026
2026
  • 14 AugdividendDividend · ₹0.50 per share+0.9%
  • 30 JulresultsResults · Q1 FY27 · consolidated and standalone-0.8%NSE
  • 21 JulshareholdingShareholding · 30 Jun 2026+0.8%NSE
  • 14 MayresultsResults · Q4 FY26 · consolidated and standalone+2.5%NSE
  • 13 AprshareholdingShareholding · 31 Mar 2026-0.4%NSE
  • 4 FebresultsResults · Q3 FY26 · consolidated and standalone-1.3%NSE
  • 13 JanshareholdingShareholding · 31 Dec 2025-2.1%NSE

Reaction to results · all yearsrose on day 0 in 8 of 15 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY2730 Jul 2026-0.8%+2.8%+3.9%2.4×
Q4 FY2614 May 2026+2.5%+2.2%+0.7%3.1×
Q3 FY264 Feb 2026-1.3%+2.3%-1.1%0.8×
Q2 FY267 Nov 2025-5.4%-4.0%-7.3%6.1×
Q1 FY267 Aug 2025+7.2%+1.2%+3.8%21.2×
Q4 FY2515 May 2025-3.4%-1.9%-4.6%3.6×
Q3 FY254 Feb 2025+10.7%+4.7%+20.3%5.1×
Q2 FY2514 Nov 2024+0.8%+2.8%+3.4%0.8×
Q1 FY258 Aug 2024-3.4%-5.8%-6.1%1.2×
Q4 FY2417 May 2024-1.2%-13.9%-3.4%0.2×
Q3 FY248 Feb 2024+0.8%+14.0%-0.3%1.8×
Q2 FY249 Nov 2023+5.0%+5.0%+8.5%1.8×
Q1 FY2410 Aug 2023-1.8%-0.2%+1.2%4.6×
Q4 FY2327 May 2023+0.8%+2.3%+14.1%1.6×
Q3 FY2313 Feb 2023+0.1%+11.2%+7.7%1.7×
Average+0.7%+1.5%+2.7%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY+26.5%
Profit YoY-1.1%
Interest cost YoY+50.7%
Revenue QoQ+12.5%
Profit QoQ+11.0%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+18.3%—————
Profit+7.0%—————

Key data

CSV
Open1,336.10
Day range1,282.00 – 1,344.70
52-week range956.00 – 1,544.00
From 52w high-15.8%
RSI (14)31.9
ATR (14)49.89
Volume3.78L
Avg volume (20D)2.57L
Rel volume1.47×
Volatility (1Y)30.2%
Turnover₹49.2Cr
SMA 50 / 2001,433.83 / 1,236.81

Delivery percentage

Latest · 6 Oct 202661.1%
20-day avg53.0%
1-year avg55.7%
Percentile (own history)69th
Range11.2–95.1%
Sessions965

Over the last 20 sessions MEDANTA settled 53.0% of its traded quantity, which is above average for an NSE equity. Its one-year average is 55.7%, so recent sessions are running 2.8 points lower than usual. The latest session ranks higher than 69% of the 965 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryHospital
PeersAPOLLOHOSPMAXHEALTHFORTISYATHARTHASTERDMMANIPALHOS

Performance returns

CSV
1D1W1M3M6M1Y
Price-2.39%-9.25%-8.22%-1.77%+30.03%+0.08%

Valuation

CSV
Market cap₹34,975 Cr
P/E (TTM)63.3
EPS (TTM)20.54
Shares outstanding26.88Cr
Listed16 Nov 2022

Ownership

CSV
Promoter33.00%
Promoter Δ QoQ-0.01 pp
Public66.91%
FII9.46%
DII16.89%
Pledged0.00%

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)1,099.21,121.01,159.01,304.1
YoY chg+14.9%+18.8%+24.5%+26.5%
Net profit (₹ Cr)158.495.0141.7157.3
YoY chg+21.1%-33.5%+39.7%-1.1%
Net margin14.4%8.5%12.2%12.1%
EPS5.893.545.345.90

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 33.00% · public 66.91%
11 Nov 2022: promoter 33.08%31 Dec 2022: promoter 33.08%31 Mar 2023: promoter 33.08%30 Jun 2023: promoter 33.07%30 Sept 2023: promoter 33.06%31 Dec 2023: promoter 33.05%31 Mar 2024: promoter 33.04%30 Jun 2024: promoter 33.04%30 Sept 2024: promoter 33.04%31 Dec 2024: promoter 33.03%31 Mar 2025: promoter 33.03%30 Jun 2025: promoter 33.01%30 Sept 2025: promoter 33.01%31 Dec 2025: promoter 33.01%31 Mar 2026: promoter 33.01%30 Jun 2026: promoter 33.00%
2022-112026-06
  • Promoter
  • Public and others
Promoter
33.00%
Public
66.91%
Promoter change
-0.01 pp
Filed
21 Jul 2026
FII
9.46%
DII
16.89%
Promoter pledged
0.00%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q2 FY24Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27
Revenue from operations843.9832.6808.6861.1956.6943.4931.21,030.81,099.21,121.01,159.01,304.1
Other income20.821.927.421.918.216.022.920.519.721.836.722.2
Total income864.7854.5836.1883.0974.8959.5954.21,051.31,118.91,142.81,195.81,326.2
Total expenses694.1682.2693.0739.4793.7770.4770.8862.7935.1986.41,008.51,113.0
└ Finance costs20.117.718.218.016.016.315.013.817.121.526.726.7
└ Depreciation42.944.045.546.649.448.449.345.149.761.266.569.0
Profit before tax170.6172.4143.1143.7181.1189.1133.4208.1199.8119.8187.3213.3
Tax expense45.448.815.737.450.346.232.149.241.424.845.656.0
Net profit125.2123.5127.3106.3130.8142.9101.4159.0158.495.0141.7157.3
EPS4.664.614.743.964.875.323.775.925.893.545.365.91
Net margin14.83%14.84%15.75%12.34%13.68%15.14%10.89%15.42%14.41%8.48%12.22%12.06%
PBT margin20.22%20.70%17.69%16.68%18.93%20.04%14.33%20.19%18.18%10.68%16.16%16.35%
Tax rate26.64%28.33%11.00%26.03%27.76%24.44%24.03%23.62%20.73%20.66%24.36%26.26%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 30 Jul 2026.

MEDANTA at a glance

  • MEDANTA closed at ₹1,300.8 on 6 Oct 2026, -2.39% on the day, +0.1% over one year, 15.8% below its 52-week high of ₹1,544.
  • Delivery was 61.1% of traded quantity on 6 Oct 2026, the 69th percentile of its own 965 sessions with a reading (20-session average 53.0%, 1-year average 55.7%).
  • Market capitalisation is ₹34,975 crore at a trailing P/E of 63.3 (trailing EPS ₹20.54).
  • Q1 FY27 results (consolidated, filed 30 Jul 2026): revenue ₹1,304 crore (+26.5% year on year), net profit ₹157 crore (-1.1%); the price moved -0.8% on the first session after.
  • Promoters held 33.00% at 30 Jun 2026, down 0.01 percentage points on the previous filing.
  • Q2 FY27 results are expected between 7 Nov 2026 and 14 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV
Macro sectorHealthcare
Basic industryHospital
ISININE474Q01031
SeriesEQ
Listed16 Nov 2022
History from16 Nov 2022
Sessions965
Turnover rank#565

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Healthcare Services

CSV

All Healthcare Services stocks on the NSEAll Healthcare stocks on the NSE